3Takada M,Fukuoka M,Furuse K,et al.Phase Ⅲ sutdy of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small cell lung cancer.Proc ASCO,1996,15:372. 被引量：1
4Johnson DH,Kim K,Sause W,et al.Cisplatin and stoposside phts thoracic radiotherapy administered once or twice daily in limited stage small cell lung cancer.Proc ASCO,1996,15:374. 被引量：1
5Brugger W,Frommhold H,Hasse J,et al.Upfront high-dose chemotherapy with peripheral blood progenitor cell transplantation in patients with limiteddisease small cell lung cancer.Proc ASCO.1995,14:326. 被引量：1
6Jennis A,Levitan N,Pecora AL,et al.Sequential high dose chemotherapy with filgrastim/peripheral stem cell support in extensive stage small cell lung cancer.Proc ASCO,1996,15:349. 被引量：1
8Viallet J,Laberge F,Martins,H,et al.Docetaxel alternating with ciaplatin and vinorelbin:Early evidence of additive activity in a phase Ⅱ trial of non-small cell lung cancer.Proc ASCO,1996,15:375. 被引量：1
9Choy H,Akerley W.Safran H,et al.Phase Ⅱ trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.Proc ASCO,1996,15:371. 被引量：1
10Xu Guangohuan,Liu Guozhen.Chemotherapy combines with radiotherapy versus radiotherapy alone for inoperable stage Ⅲ non-small cell lung cancer.Proc ASCO,1996,13:631. 被引量：1
5Nakanishi Y,Inoue K,Hara N.Treatment of lung cancer-state of the art in 2000. Gan To Kagaku Ryoho,2000,27 : 1247-1252. 被引量：1
6William B, Williams D. Mechanisms of drug resistance [A].In: De Vita VT, Helman S, Rosenberg SA, eds. Cancer,principles & practice of oncology [M]. 5th Ed. Philadephia:Lippincott-Raven Publishers, 1997: 498-509. 被引量：1
7Ettinger DS. Is there a preferred combination chemotherapy regimen for nonsmall cell lung cancer [J]. Oncologist, 2002,7 (3): 226-233. 被引量：1
8Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay [J]. J Immunol Method , 1983, 65 (1-2): 55-63. 被引量：1
9Parker SL, Tong T , Bolden S, et al. Cancer statistics [J].Cancer J Clin, 1996, 65: 5-27. 被引量：1
10Harper JW, Adami GR, Wei N, et al. The p21 cdkinteracting protein Cip1 is a potent inhibitor of G1 cyclindependent kinases [J]. Cell Biology, 1995, 75: 805-816. 被引量：1
